Product Details
(FHV/FCV/CF/MF) Feline herpes virus /Feline Calici virus /
Chlamydia / Mycoplasma PCR Fluorescence Probe Kits
Intend for Use
This kit is intended for the specific detection of feline herpes
virus (FHV), feline calici virus (FCV), chlamydia feline(CF),
mycoplasma feline(MF) in samples from cat eyes, mouth and nasal
secretions.
Principle
In the presence of highly efficient retroenzymes, the cDNA strand
was synthesized complementary to the RNA as the template and the
primer as the starting point.Choose cat herpes virus, cat
gobicivirus, chlamydia and mycoplasma conserved gene fragment
design specific probes, the probe can primer template DNA
amplification region, in the PCR extension process, the exonuclease
activity of Taq enzyme from the probe, free in the reaction system,
thus from the 3 ′ end quenching group, fluorescence, through the
fluorescence PCR instrument, realize the cat in a fully closed
reaction system Detection of herpesviruses, cat calici viruses,
Chlamydia, and Mycoplasma nucleic acids.
Component
Component | No. |
FHV/FCV PCR reagent | 8 tubes |
CF/MF PCR reagnet | 8 Tubes |
Positive Control | 1 Tube |
Negative Control | 1 Tube |
Company Profile
Bio key Health is a high-tech enterprise with integrating R&D,
production and sales&marketing in Guangzhou. Since 2003. Bio
Key was founded by the "Thousand Talents Program" entrepreneurial
team and the overseas senior automation equipment development
engineer team.
The company's core team has been in the field of IVD research and
entrepreneurship for more than 10 years, and has mastered a wealth
of molecular diagnostic POCT industrial application technology,
SmartTRF immune detection technology, RT qPCR nucleic acid
detection technology and independent research and development
capabilities of instruments.
It has a number of independent core technologies in the fields of
automation engineering, micro-precision manufacturing,
immunofluorescence, nucleic acid detection and gene sequencing.
Since its establishment, the company has applied for more than 60
patents and currently has 17 authorized patents. The company has
two R&D centers for diagnostic reagents and instruments and
equipment, totaling more than 500 square meters; it has established
more than 2,000 square meters of GMP workshops and equipment
production plants; it has SmartTRF new immune detection technology,
nucleic acid detection technology (POCT) and three scientific
services.